Luis Correia Pinheiro
Den Haag, Zuid-Holland, Nederland
1K volgers
Meer dan 500 connecties
Info
I am a pharmacoepidemiologist and data scientist with a 20-year experience as researcher, regulator and manager.
My current role at the European Medicines Agency (EMA) focuses on leveraging AI, machine learning, natural language processing and new digital technologies to deliver new solutions for healthcare data analytics, delivering on the multi-annual AI Workplan as well as on conducting real-world data studies.
Activiteit
-
After three years in incubation, the data science team at the Swedish Medical Products Agency (Läkemedelsverket) is ready to carry its own…
After three years in incubation, the data science team at the Swedish Medical Products Agency (Läkemedelsverket) is ready to carry its own…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
Congratulations to our lead of the Biosemantics research group Jan Kors for working 40 years at Erasmus MC at the Department of Medical Informatics!…
Congratulations to our lead of the Biosemantics research group Jan Kors for working 40 years at Erasmus MC at the Department of Medical Informatics!…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
Den europeiska läkemedelsmyndighetens vetenskapliga kommitté för säkerhetsövervakning och riskbedömning av läkemedel, PRAC, har en avgörande…
Den europeiska läkemedelsmyndighetens vetenskapliga kommitté för säkerhetsövervakning och riskbedömning av läkemedel, PRAC, har en avgörande…
Gemarkeerd als interessant door Luis Correia Pinheiro
Ervaring
Opleiding
Publicaties
-
Indications for Systemic Fluoroquinolone Therapy in Europe and Prevalence of Primary-Care Prescribing in France, Germany and the UK: Descriptive Population-Based Study
August 2018 · Clinical Drug Investigation 38(Suppl 1)
-
An algorithm to detect unexpected increases in frequency of reports of adverse events in EudraVigilance
Pharmacoepidemiology and Drug Safety
Onderscheidingen
-
Best Reviewers 2014
Pharmacoepidemiology and Drug Safety
The quality and timeliness of your review for Pharmacoepidemiology and Drug Safety placed the work you did for us among the best of all reviews in 2014. We thank you, and wish to inspire you to sustain your high standards. Further, because we are interested in giving more credit to reviewers like you who provide exceptional service to medical science in this important role, I would encourage you to send a copy of this letter to others who should be aware of it, and to note on your curriculum…
The quality and timeliness of your review for Pharmacoepidemiology and Drug Safety placed the work you did for us among the best of all reviews in 2014. We thank you, and wish to inspire you to sustain your high standards. Further, because we are interested in giving more credit to reviewers like you who provide exceptional service to medical science in this important role, I would encourage you to send a copy of this letter to others who should be aware of it, and to note on your curriculum vitae (CV) the honor conveyed by it.
Talen
-
English
Volledige professionele vaardigheid
-
Spanish
Professionele werkvaardigheid
-
French
Basisvaardigheid
-
Portuguese
Moedertaal of tweetalig
Meer activiteiten van Luis
-
Thank you for the invitation to speakk and the exciting discussion on #AI at the Regulatory Science Network Netherlands! I particularly enjoyed the…
Thank you for the invitation to speakk and the exciting discussion on #AI at the Regulatory Science Network Netherlands! I particularly enjoyed the…
Gedeeld door Luis Correia Pinheiro
-
Science, regulation and fun discussing LLM use in regulatory science and in the medicines lifecycle. Swissmedic were expert moderators and…
Science, regulation and fun discussing LLM use in regulatory science and in the medicines lifecycle. Swissmedic were expert moderators and…
Gedeeld door Luis Correia Pinheiro
-
Last week, I had the privilege of presenting at the European Medicines Agency Development Day! 🌟 I discussed the topic of Readiness of AI…
Last week, I had the privilege of presenting at the European Medicines Agency Development Day! 🌟 I discussed the topic of Readiness of AI…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
I am a big advocate of continuous learning through regular trainings, exchange of practices and strong collaboration. The Covid-19 pandemic…
I am a big advocate of continuous learning through regular trainings, exchange of practices and strong collaboration. The Covid-19 pandemic…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
EU Network Training Centre (EU NTC) 10-year anniversary event - 30 May 2024 – Amsterdam, The Netherlands True pleasure and so much fun to have…
EU Network Training Centre (EU NTC) 10-year anniversary event - 30 May 2024 – Amsterdam, The Netherlands True pleasure and so much fun to have…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
A great epidemiologist, all-round nice guy and Sean Connery lookalike is returning to his alma mater leaving us with a seconded national expert…
A great epidemiologist, all-round nice guy and Sean Connery lookalike is returning to his alma mater leaving us with a seconded national expert…
Gedeeld door Luis Correia Pinheiro
-
OHDSI Europe is Fully Booked. 350 attendees at the Symposium at the SS Rotterdam on Monday and 200 participants for the tutorials at the Erasmus MC…
OHDSI Europe is Fully Booked. 350 attendees at the Symposium at the SS Rotterdam on Monday and 200 participants for the tutorials at the Erasmus MC…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
Pharmacovigilance #Risk Assessment Committee (PRAC) strategic review and learning meeting in #Belgium under the #Belgian #presidency of the council…
Pharmacovigilance #Risk Assessment Committee (PRAC) strategic review and learning meeting in #Belgium under the #Belgian #presidency of the council…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
Today we focus on the future of #clinicaltrials at the 5th Nordic #Pediatric Clinical trials Luis Correia Pinheiro describs the usefulness of #AI in…
Today we focus on the future of #clinicaltrials at the 5th Nordic #Pediatric Clinical trials Luis Correia Pinheiro describs the usefulness of #AI in…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
I had the honour to participate in the signing of a new confidentiality arrangement between the European Commission, the European Medicines Agency…
I had the honour to participate in the signing of a new confidentiality arrangement between the European Commission, the European Medicines Agency…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
It’s always great to be (by far) the least qualified person on the panel! 🗓️ Drop along and hear Bakul Patel , Alastair, and myself chat to David…
It’s always great to be (by far) the least qualified person on the panel! 🗓️ Drop along and hear Bakul Patel , Alastair, and myself chat to David…
Gemarkeerd als interessant door Luis Correia Pinheiro
-
Gostaria de compartilhar que recebi uma nova certificação: Curso de Especialização em Monitorização e Investigação em Ensaios Clínicos da empresa…
Gostaria de compartilhar que recebi uma nova certificação: Curso de Especialização em Monitorização e Investigação em Ensaios Clínicos da empresa…
Gemarkeerd als interessant door Luis Correia Pinheiro
Overige vergelijkbare profielen
Anderen hebben Luis Correia Pinheiro genoemd
1 andere persoon door wie Luis Correia Pinheiro is genoemd, gebruikt LinkedIn
Bekijk anderen die Luis Correia Pinheiro heten